Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Joo WD et al. – The authors could choose a combination of taxane and platinum which did not show EDR and could obtain a good response in the patients with ovarian cancer.

Related Articles

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09    Relevance Score: 72%

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09    Relevance Score: 70%

Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09    Relevance Score: 70%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 70%

New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09    Relevance Score: 70%

Today in Clinical Pharmacology...keeping you current

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
International Journal of Women's Health, 12/18/09

Dienogest: a new therapeutic agent for the treatment of endometriosis
Women's Health, 12/17/09

Association of high-dose bifonazole administration during early pregnancy and severe limb reduction defects in the newborn
Birth Defects Research, 12/17/09

Today in Gynecologic Oncology...keeping you current

Quality of life and satisfaction after breast cancer operation
Archives of Gynecology and Obstetrics, 12/18/09

Colloid carcinoma of the intestinal type in the uterine cervix: Mucin immunohistochemistry
Pathology International, 12/18/09

The prevalence of abnormal cervical cytology in women with infertility
Diagnostic Cytopathology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address